(WAY) Waystar Holding Common Stock - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9467841055
Stock: Cloud-Based, Healthcare, Payments, Analytics
Total Rating 29
Risk 69
Buy Signal -1.15
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 37.2% |
| Relative Tail Risk | -7.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.26 |
| Alpha | -55.27 |
| Character TTM | |
|---|---|
| Beta | 0.787 |
| Beta Downside | 0.812 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.10% |
| CAGR/Max DD | 0.22 |
Description: WAY Waystar Holding Common Stock January 08, 2026
Waystar Holding Corp. (NASDAQ: WAY) provides a cloud-based platform that streamlines healthcare payments, covering financial clearance, patient financial care, claim and payment management, denial prevention, revenue capture, and analytics. Founded in 2017 and headquartered in Lehi, Utah, the company serves hospitals, health systems, and other providers across the United States.
Key recent metrics: FY 2023 revenue reached approximately $560 million, up ~30% year-over-year, driven by strong adoption of its revenue-cycle management suite; gross margins have consistently hovered around 80%, reflecting the scalability of its SaaS model; and its annual recurring revenue (ARR) now exceeds $400 million, indicating a solid subscription base. The broader health-care technology sector is being propelled by the shift to value-based care and increasing pressure on providers to reduce administrative costs, both of which favor integrated payment-automation solutions like Waystar’s.
For a deeper dive into WAY’s valuation metrics and scenario analysis, the ValueRay platform offers up-to-date analytics you may find useful.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 111.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.02 > 1.0 |
| NWC/Revenue: 43.85% < 20% (prev 19.02%; Δ 24.83% < -1%) |
| CFO/TA 0.06 > 3% & CFO 307.8m > Net Income 111.2m |
| Net Debt (-380.3m) to EBITDA (380.7m): -1.00 < 3 |
| Current Ratio: 3.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (181.2m) vs 12m ago 2.87% < -2% |
| Gross Margin: 67.78% > 18% (prev 0.67%; Δ 6711 % > 0.5%) |
| Asset Turnover: 22.39% > 50% (prev 19.96%; Δ 2.44% > 0%) |
| Interest Coverage Ratio: 3.28 > 6 (EBITDA TTM 380.7m / Interest Expense TTM 73.9m) |
Altman Z'' 0.80
| A: 0.10 (Total Current Assets 613.6m - Total Current Liabilities 157.7m) / Total Assets 4.75b |
| B: -0.03 (Retained Earnings -128.8m / Total Assets 4.75b) |
| C: 0.05 (EBIT TTM 242.5m / Avg Total Assets 4.64b) |
| D: -0.08 (Book Value of Equity -127.6m / Total Liabilities 1.52b) |
| Altman-Z'' Score: 0.80 = B |
Beneish M -3.08
| DSRI: 0.92 (Receivables 145.7m/137.9m, Revenue 1.04b/906.1m) |
| GMI: 0.98 (GM 67.78% / 66.52%) |
| AQI: 0.93 (AQ_t 0.86 / AQ_t-1 0.92) |
| SGI: 1.15 (Revenue 1.04b / 906.1m) |
| TATA: -0.04 (NI 111.2m - CFO 307.8m) / TA 4.75b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of WAY shares?
As of February 07, 2026, the stock is trading at USD 24.30 with a total of 2,615,841 shares traded.
Over the past week, the price has changed by -8.51%, over one month by -25.30%, over three months by -32.12% and over the past year by -40.64%.
Over the past week, the price has changed by -8.51%, over one month by -25.30%, over three months by -32.12% and over the past year by -40.64%.
Is WAY a buy, sell or hold?
Waystar Holding Common Stock has received a consensus analysts rating of 4.69.
Therefore, it is recommended to buy WAY.
- StrongBuy: 9
- Buy: 4
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WAY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46.9 | 93% |
| Analysts Target Price | 46.9 | 93% |
| ValueRay Target Price | 20.8 | -14.3% |
WAY Fundamental Data Overview February 03, 2026
P/E Trailing = 40.8615
P/E Forward = 16.9492
P/S = 4.8867
P/B = 1.5857
Revenue TTM = 1.04b USD
EBIT TTM = 242.5m USD
EBITDA TTM = 380.7m USD
Long Term Debt = 1.21b USD (from longTermDebt, last quarter)
Short Term Debt = 18.3m USD (from shortTermDebt, last quarter)
Debt = 40.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -380.3m USD (from netDebt column, last quarter)
Enterprise Value = 4.70b USD (5.08b + Debt 40.7m - CCE 421.1m)
Interest Coverage Ratio = 3.28 (Ebit TTM 242.5m / Interest Expense TTM 73.9m)
EV/FCF = 16.52x (Enterprise Value 4.70b / FCF TTM 284.5m)
FCF Yield = 6.05% (FCF TTM 284.5m / Enterprise Value 4.70b)
FCF Margin = 27.36% (FCF TTM 284.5m / Revenue TTM 1.04b)
Net Margin = 10.69% (Net Income TTM 111.2m / Revenue TTM 1.04b)
Gross Margin = 67.78% ((Revenue TTM 1.04b - Cost of Revenue TTM 335.1m) / Revenue TTM)
Gross Margin QoQ = 68.31% (prev 67.84%)
Tobins Q-Ratio = 0.99 (Enterprise Value 4.70b / Total Assets 4.75b)
Interest Expense / Debt = 40.79% (Interest Expense 16.6m / Debt 40.7m)
Taxrate = 28.25% (12.1m / 42.7m)
NOPAT = 174.0m (EBIT 242.5m * (1 - 28.25%))
Current Ratio = 3.89 (Total Current Assets 613.6m / Total Current Liabilities 157.7m)
Debt / Equity = 0.01 (Debt 40.7m / totalStockholderEquity, last quarter 3.22b)
Debt / EBITDA = -1.00 (Net Debt -380.3m / EBITDA 380.7m)
Debt / FCF = -1.34 (Net Debt -380.3m / FCF TTM 284.5m)
Total Stockholder Equity = 3.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.39% (Net Income 111.2m / Total Assets 4.75b)
RoE = 3.53% (Net Income TTM 111.2m / Total Stockholder Equity 3.15b)
RoCE = 5.56% (EBIT 242.5m / Capital Employed (Equity 3.15b + L.T.Debt 1.21b))
RoIC = 3.97% (NOPAT 174.0m / Invested Capital 4.38b)
WACC = 8.98% (E(5.08b)/V(5.12b) * Re(8.82%) + D(40.7m)/V(5.12b) * Rd(40.79%) * (1-Tc(0.28)))
Discount Rate = 8.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.28%
[DCF Debug] Terminal Value 78.13% ; FCFF base≈206.6m ; Y1≈254.8m ; Y5≈433.9m
Fair Price DCF = 33.93 (EV 6.11b - Net Debt -380.3m = Equity 6.49b / Shares 191.3m; r=8.98% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 92.18 | EPS CAGR: 791.6% | SUE: 0.14 | # QB: 0
Revenue Correlation: 99.25 | Revenue CAGR: 14.22% | SUE: 1.16 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.39 | Chg30d=+0.001 | Revisions Net=-1 | Analysts=16
EPS next Year (2026-12-31): EPS=1.63 | Chg30d=-0.012 | Revisions Net=-1 | Growth EPS=+12.0% | Growth Revenue=+17.7%
P/E Forward = 16.9492
P/S = 4.8867
P/B = 1.5857
Revenue TTM = 1.04b USD
EBIT TTM = 242.5m USD
EBITDA TTM = 380.7m USD
Long Term Debt = 1.21b USD (from longTermDebt, last quarter)
Short Term Debt = 18.3m USD (from shortTermDebt, last quarter)
Debt = 40.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -380.3m USD (from netDebt column, last quarter)
Enterprise Value = 4.70b USD (5.08b + Debt 40.7m - CCE 421.1m)
Interest Coverage Ratio = 3.28 (Ebit TTM 242.5m / Interest Expense TTM 73.9m)
EV/FCF = 16.52x (Enterprise Value 4.70b / FCF TTM 284.5m)
FCF Yield = 6.05% (FCF TTM 284.5m / Enterprise Value 4.70b)
FCF Margin = 27.36% (FCF TTM 284.5m / Revenue TTM 1.04b)
Net Margin = 10.69% (Net Income TTM 111.2m / Revenue TTM 1.04b)
Gross Margin = 67.78% ((Revenue TTM 1.04b - Cost of Revenue TTM 335.1m) / Revenue TTM)
Gross Margin QoQ = 68.31% (prev 67.84%)
Tobins Q-Ratio = 0.99 (Enterprise Value 4.70b / Total Assets 4.75b)
Interest Expense / Debt = 40.79% (Interest Expense 16.6m / Debt 40.7m)
Taxrate = 28.25% (12.1m / 42.7m)
NOPAT = 174.0m (EBIT 242.5m * (1 - 28.25%))
Current Ratio = 3.89 (Total Current Assets 613.6m / Total Current Liabilities 157.7m)
Debt / Equity = 0.01 (Debt 40.7m / totalStockholderEquity, last quarter 3.22b)
Debt / EBITDA = -1.00 (Net Debt -380.3m / EBITDA 380.7m)
Debt / FCF = -1.34 (Net Debt -380.3m / FCF TTM 284.5m)
Total Stockholder Equity = 3.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.39% (Net Income 111.2m / Total Assets 4.75b)
RoE = 3.53% (Net Income TTM 111.2m / Total Stockholder Equity 3.15b)
RoCE = 5.56% (EBIT 242.5m / Capital Employed (Equity 3.15b + L.T.Debt 1.21b))
RoIC = 3.97% (NOPAT 174.0m / Invested Capital 4.38b)
WACC = 8.98% (E(5.08b)/V(5.12b) * Re(8.82%) + D(40.7m)/V(5.12b) * Rd(40.79%) * (1-Tc(0.28)))
Discount Rate = 8.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.28%
[DCF Debug] Terminal Value 78.13% ; FCFF base≈206.6m ; Y1≈254.8m ; Y5≈433.9m
Fair Price DCF = 33.93 (EV 6.11b - Net Debt -380.3m = Equity 6.49b / Shares 191.3m; r=8.98% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 92.18 | EPS CAGR: 791.6% | SUE: 0.14 | # QB: 0
Revenue Correlation: 99.25 | Revenue CAGR: 14.22% | SUE: 1.16 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.39 | Chg30d=+0.001 | Revisions Net=-1 | Analysts=16
EPS next Year (2026-12-31): EPS=1.63 | Chg30d=-0.012 | Revisions Net=-1 | Growth EPS=+12.0% | Growth Revenue=+17.7%